Fr. 57.50

THE CAGUT - Results of its implementation in patients with chronic pelvic inflammatory disease.

English · Paperback / Softback

Shipping usually within 2 to 3 weeks (title will be printed to order)

Description

Read more

The book deals with the results of a prospective descriptive longitudinal study in Guantánamo, with the objective of evaluating the response to the treatment with catgut-therapy of Chronic Pelvic Inflammatory Disease in the period January - December 2023. When carrying out the clinical epidemiological characterization, women of the age groups 20-24 and 25-29, accompanied and with university level of schooling, predominated. Most of the patients evolved favorably with the applied therapy; the catgut implantation had a positive influence on the relief and disappearance of symptoms and other discomforts that had an unfavorable impact on their well-being and led to a reduction in the demands for medical services due to the affectation of the combative disposition. There was no increase in expected adverse reactions in general and no serious and unexpected events were identified in the course of treatment.

About the author










Lizandra Espinoza Carás: Doktor der Medizin, Fachärztin für allgemeine umfassende Medizin, Professorin und Forscherin an der Universität für medizinische Wissenschaften von Guantánamo.

Product details

Authors Lizandra Espinosa Carás, Mirtha María Peláez Vega
Publisher Our Knowledge Publishing
 
Languages English
Product format Paperback / Softback
Released 01.01.2024
 
EAN 9786207615742
ISBN 9786207615742
No. of pages 52
Subject Natural sciences, medicine, IT, technology > Medicine > Holistic medicine

Customer reviews

No reviews have been written for this item yet. Write the first review and be helpful to other users when they decide on a purchase.

Write a review

Thumbs up or thumbs down? Write your own review.

For messages to CeDe.ch please use the contact form.

The input fields marked * are obligatory

By submitting this form you agree to our data privacy statement.